Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma.
Feng C, Li T, Xiao J, Wang J, Meng X, Niu H, Jiang B, Huang L, Deng X, Yan X, Wu D, Fang Y, Lin Y, Chen F, Wu X, Zhao X, Feng J.
Feng C, et al. Among authors: lin y.
Front Cell Dev Biol. 2022 Apr 14;10:814836. doi: 10.3389/fcell.2022.814836. eCollection 2022.
Front Cell Dev Biol. 2022.
PMID: 35493068
Free PMC article.